30 June 2020
The TGA has issued two infringement notices totalling $25,200 to Sydney-based company Pfeffer Contracting for alleged unlawful advertising in relation to COVID-19.
29 June 2020
The TGA has issued two infringement notices totalling $25,200 to Sydney-based company Australian Chemical Research for alleged breaches in relation to hand sanitiser.
29 June 2020
The TGA has issued three infringement notices totalling $7,560 to a woman based in Brisbane for alleged unlawful advertising in relation to COVID-19.
17 June 2020
The TGA has issued five infringement notices totalling $63,000 to Sydney-based company Chemforce Pty Ltd for alleged unlawful advertising in relation to COVID-19.
15 June 2020
The TGA has issued four infringement notices totalling $50,400 to Cairns based company Hydrogen Technologies Pty Ltd for alleged advertising breaches including reference to COVID-19.
4 June 2020
The Federal Court of Australia has made orders restraining MMS Australia from advertising and supplying goods containing certain potentially dangerous substances, including the main chemical used to make 'Miracle Mineral Solution' (MMS), until a further hearing next week.
29 May 2020
The TGA has initiated proceedings in the Federal Court of Australia in response to the alleged unlawful advertising of Miracle Mineral Supplement (MMS), dimethyl sulfoxide (DMSO) and other medicines by Southern Cross Directories Pty Ltd trading as MMS Australia.
28 May 2020
The TGA is reminding advertisers that therapeutic goods advertising must not undermine public health campaigns, as the cold and flu season begins in Australia and COVID-19 restrictions are eased.
22 May 2020
The TGA has issued a $12,600 infringement notice to Melbourne based company NutriPATH Pty Ltd for the alleged unlawful advertising of a COVID-19 Polymerase Chain Reaction (PCR) test collection kit.
21 May 2020
The TGA has issued fifteen infringement notices totalling $37,800 to a doctor in Perth, including alleged unlawful advertising of therapeutic goods in relation to COVID-19.